Stephen W. Webster, Director at Nabriva Therapeutics plc (NBRV), sold 777 shares at $1.20 ($932) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Open-market sale of $932 NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBRV | BUY | 2018-05-23 | $37K | — | Filing → |
| ONCE | SELL | 2017-11-20 | $701K | — | Filing → |
| ONCE | SELL | 2017-08-15 | $794K | — | Filing → |